Research at Hospital for Special Surgery is focused on identifying mechanisms underlying musculoskeletal and autoimmune conditions, and discovering and developing effective approaches for prevention, diagnosis, and treatment of orthopedic and rheumatic diseases.
Dr. Mary Goldring, senior scientist at Hospital for Special Surgery (HSS) in New York City, has been named president of the Orthopaedic Research Society (ORS). The inauguration took place at the organizationís annual meeting on March 17 in New Orleans, with more than 2600 attendees. Learn More.
Registries provide the foundation for clinical trials, translational research, and treatment innovation. HSS has created more than 30 registries including the Hip, Knee and Shoulder Arthroplasty Registries, Sports Medicine and Shoulder Services ACL Registry, Center for Hip Preservation Registry, Autoimmune Disease Registry, and Scleroderma Registry. Read more and learn how to participate
Jane Salmon, MD is Principal Investigator on a multi-center NIH-funded research initiative, the PROMISSE study, to identify predictors of poor pregnancy outcomes in women with systemic lupus erythematosus (SLE). The study is providing insights on the genes and cellular pathways that can affect pregnancy in lupus patients and, potentially, cause miscarriage and preeclampsia in healthy women. Learn more